Current Approaches in Development of Immunotherapeutic Vaccines for Breast Cancer
- PMID: 30607155
- PMCID: PMC6310717
- DOI: 10.4048/jbc.2018.21.e47
Current Approaches in Development of Immunotherapeutic Vaccines for Breast Cancer
Abstract
Cancer is the leading cause of death worldwide. In developed as well as developing countries, breast cancer is the most common cancer found among women. Currently, treatment of breast cancer consists mainly of surgery, chemotherapy, hormone therapy, and radiotherapy. In recent years, because of increased understanding of the therapeutic potential of immunotherapy in cancer prevention, cancer vaccines have gained importance. Here, we review various immunotherapeutic breast cancer vaccines including peptide-based vaccines, whole tumor cell vaccines, gene-based vaccines, and dendritic cell vaccines. We also discuss novel nanotechnology-based approaches to improving breast cancer vaccine efficiency.
Keywords: Breast neoplasms; Immunology; Immunotherapy; Vaccines.
Conflict of interest statement
CONFLICT OF INTEREST: The authors declare that they have no competing interests.
References
-
- American Cancer Society. Cancer Facts & Figures 2018. Atlanta: American Cancer Society; 2018.
-
- Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBACAN 2012 v1.0. Cancer ıncidence and mortality worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer; [Accessed May 30th, 2018]. http://globocan.iarc.fr.
-
- Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thürlimann B, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol. 2013;24:2206–2223. - PMC - PubMed
-
- Pham PV. Breast Cancer Stem Cells & Therapy Resistance. Cham: Springer International Publishing; 2015.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
